Achiron A - Search Results

1

Zinc-ion binding and cytokine activity regulation pathways predicts outcome in relapsing-remitting multiple sclerosis.

Achiron A, Gurevich M, Snir Y, Segal E, Mandel M. Achiron A, et al. Clin Exp Immunol. 2007 Aug;149(2):235-42. doi: 10.1111/j.1365-2249.2007.03405.x. Epub 2007 May 4. Clin Exp Immunol. 2007. PMID: 17488294 Free PMC article.

2

Open controlled therapeutic trial of intravenous immune globulin in relapsing-remitting multiple sclerosis.

Achiron A, Pras E, Gilad R, Ziv I, Mandel M, Gordon CR, Noy S, Sarova-Pinhas I, Melamed E. Achiron A, et al. Arch Neurol. 1992 Dec;49(12):1233-6. doi: 10.1001/archneur.1992.00530360031013. Arch Neurol. 1992. PMID: 1449400

3

A new approach to affective symptoms in relapsing-remitting multiple sclerosis.

Noy S, Achiron A, Gabbay U, Barak Y, Rotstein Z, Laor N, Sarova-Pinhas I. Noy S, et al. Among authors: achiron a. Compr Psychiatry. 1995 Sep-Oct;36(5):390-5. doi: 10.1016/s0010-440x(95)90121-3. Compr Psychiatry. 1995. PMID: 7497714 Free article.

4

Intravenous immune globulin in multiple sclerosis: clinical and neuroradiological results and implications for possible mechanisms of action.

Achiron A, Barak Y, Goren M, Gabbay U, Miron S, Rotstein Z, Noy S, Sarova-Pinhas I. Achiron A, et al. Clin Exp Immunol. 1996 May;104 Suppl 1:67-70. Clin Exp Immunol. 1996. PMID: 8625547 Free article. Clinical Trial.

5

Electrical sensation during Tai-Chi practice as the first manifestation of multiple sclerosis.

Achiron A, Barak Y, Stern Y, Noy S. Achiron A, et al. Clin Neurol Neurosurg. 1997 Dec;99(4):280-1. doi: 10.1016/s0303-8467(97)00103-0. Clin Neurol Neurosurg. 1997. PMID: 9491306

6

Juvenile multiple sclerosis: clinical features and prognostic characteristics.

Pinhas-Hamiel O, Barak Y, Siev-Ner I, Achiron A. Pinhas-Hamiel O, et al. Among authors: achiron a. J Pediatr. 1998 Apr;132(4):735-7. doi: 10.1016/s0022-3476(98)70371-3. J Pediatr. 1998. PMID: 9580781

7

Multiple sclerosis-from probable to definite diagnosis: a 7-year prospective study.

Achiron A, Barak Y. Achiron A, et al. Arch Neurol. 2000 Jul;57(7):974-9. doi: 10.1001/archneur.57.7.974. Arch Neurol. 2000. PMID: 10891979 Clinical Trial.

8

[Intravenous immunoglobulins (IVIg) in the treatment of multiple sclerosis].

Achiron A, Miron S. Achiron A, et al. Ann Med Interne (Paris). 2000 May;151 Suppl 1:1S41-4. Ann Med Interne (Paris). 2000. PMID: 10896988 Review. French.

9

APOE genotype is a major predictor of long-term progression of disability in MS.

Chapman J, Vinokurov S, Achiron A, Karussis DM, Mitosek-Szewczyk K, Birnbaum M, Michaelson DM, Korczyn AD. Chapman J, et al. Among authors: achiron a. Neurology. 2001 Feb 13;56(3):312-6. doi: 10.1212/wnl.56.3.312. Neurology. 2001. PMID: 11171894

10

Late-onset multiple sclerosis.

Polliack ML, Barak Y, Achiron A. Polliack ML, et al. Among authors: achiron a. J Am Geriatr Soc. 2001 Feb;49(2):168-71. doi: 10.1046/j.1532-5415.2001.49038.x. J Am Geriatr Soc. 2001. PMID: 11207871

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

435 results

Search Page

Filters